156 related articles for article (PubMed ID: 20443017)
1. Upregulation of IGF2 is associated with an acquired resistance for cis-diamminedichloroplatinum in human head and neck squamous cell carcinoma.
Ogawa T; Ogawa K; Shiga K; Furukawa T; Nagase H; Hashimoto S; Kobayashi T; Horii A
Eur Arch Otorhinolaryngol; 2010 Oct; 267(10):1599-606. PubMed ID: 20443017
[TBL] [Abstract][Full Text] [Related]
2. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
3. Differentially expressed genes associated with CIS-diamminedichloroplatinum (II) resistance in head and neck cancer using differential display and CDNA microarray.
Higuchi E; Oridate N; Furuta Y; Suzuki S; Hatakeyama H; Sawa H; Sunayashiki-Kusuzaki K; Yamazaki K; Inuyama Y; Fukuda S
Head Neck; 2003 Mar; 25(3):187-93. PubMed ID: 12599285
[TBL] [Abstract][Full Text] [Related]
4. KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma.
Jiffar T; Yilmaz T; Lee J; Hanna E; El-Naggar A; Yu D; Myers JN; Kupferman ME
Oncogene; 2011 Jul; 30(28):3163-73. PubMed ID: 21383688
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma.
Osman AA; Arslan E; Bartels M; Michikawa C; Lindemann A; Tomczak K; Yu W; Sandulache V; Ma W; Shen L; Wang J; Singh AK; Frederick MJ; Spencer ND; Kovacs J; Heffernan T; Symmans WF; Rai K; Myers JN
Clin Cancer Res; 2023 Apr; 29(7):1344-1359. PubMed ID: 36689560
[TBL] [Abstract][Full Text] [Related]
6. [Up-regulation of human chorionic gonadotropin alpha subunit gene and human mitochondrial cytochrome c oxidase subunit II gene in cis-Diamminedichloroplatinum(II)-resistant human head and neck squamous carcinoma cells].
Higuchi E
Hokkaido Igaku Zasshi; 1999 May; 74(3):231-8. PubMed ID: 10422566
[TBL] [Abstract][Full Text] [Related]
7. A Human Head and Neck Squamous Cell Carcinoma Cell Line with Acquired cis-Diamminedichloroplatinum-Resistance Shows Remarkable Upregulation of BRCA1 and Hypersensitivity to Taxane.
Saiki Y; Ogawa T; Shiga K; Sunamura M; Kobayashi T; Horii A
Int J Otolaryngol; 2011; 2011():521852. PubMed ID: 22046189
[TBL] [Abstract][Full Text] [Related]
8. miR-34a is downregulated in cis-diamminedichloroplatinum treated sinonasal squamous cell carcinoma patients with poor prognosis.
Ogawa T; Saiki Y; Shiga K; Chen N; Fukushige S; Sunamura M; Nagase H; Hashimoto S; Matsuura K; Saijo S; Kobayashi T; Horii A
Cancer Sci; 2012 Sep; 103(9):1737-43. PubMed ID: 22624980
[TBL] [Abstract][Full Text] [Related]
9. A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels.
Tonigold M; Rossmann A; Meinold M; Bette M; Märken M; Henkenius K; Bretz AC; Giel G; Cai C; Rodepeter FR; Beneš V; Grénman R; Carey TE; Lage H; Stiewe T; Neubauer A; Werner JA; Brendel C; Mandic R
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1689-704. PubMed ID: 24913304
[TBL] [Abstract][Full Text] [Related]
10. A cDNA microarray analysis identifies 52 genes associated with cis-diamminedichloroplatinum susceptibility in head and neck squamous cell carcinoma cell lines.
Ogawa T; Furukawa T; Shiga K; Hashimoto S; Ogawa K; Kobayashi T; Horii A
Eur Arch Otorhinolaryngol; 2010 Jan; 267(1):123-9. PubMed ID: 19381670
[TBL] [Abstract][Full Text] [Related]
11. p22phox confers resistance to cisplatin, by blocking its entry into the nucleus.
Hung CC; Chien CY; Chiang WF; Lin CS; Hour TC; Chen HR; Wang LF; Ko JY; Chang CH; Chen JY
Oncotarget; 2015 Feb; 6(6):4110-25. PubMed ID: 25686830
[TBL] [Abstract][Full Text] [Related]
12. Novel mechanism of cisplatin resistance in head and neck squamous cell carcinoma involving extracellular vesicles and a copper transporter system.
Ogawa T; Ono K; Ryumon S; Kawai H; Nakamura T; Umemori K; Yoshida K; Kanemoto H; Obata K; Yoshioka N; Okui T; Okamoto K; Nagatsuka H; Ibaragi S
Head Neck; 2024 Mar; 46(3):636-650. PubMed ID: 38164660
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated fibroblast-conditioned medium induces CDDP resistance in HNSCC cells.
Steinbichler TB; Metzler V; Pritz C; Riechelmann H; Dudas J
Oncotarget; 2016 Jan; 7(3):2508-18. PubMed ID: 26497215
[TBL] [Abstract][Full Text] [Related]
15. CXCR4 enhances cisplatin resistance of human tongue squamous cell carcinoma.
Zhuang XM; Zhou B
J Oral Pathol Med; 2019 Feb; 48(2):122-128. PubMed ID: 30554431
[TBL] [Abstract][Full Text] [Related]
16. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-conjugating enzyme UBE2Q2 suppresses cell proliferation and is down-regulated in recurrent head and neck cancer.
Maeda H; Miyajima N; Kano S; Tsukiyama T; Okumura F; Fukuda S; Hatakeyama S
Mol Cancer Res; 2009 Sep; 7(9):1553-62. PubMed ID: 19723876
[TBL] [Abstract][Full Text] [Related]
18. Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro.
Rigalli JP; Reuter T; Herold-Mende C; Dyckhoff G; Haefeli WE; Weiss J; Theile D
Cancer Chemother Pharmacol; 2013 May; 71(5):1335-43. PubMed ID: 23479137
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of cisplatin-resistant human epidermoid carcinoma cell line, A431 cell.
Mese H; Sasaki A; Alcalde RE; Nakayama S; Matsumura T
Chemotherapy; 1998; 44(6):414-20. PubMed ID: 9755302
[TBL] [Abstract][Full Text] [Related]
20. Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma.
Yamano Y; Uzawa K; Saito K; Nakashima D; Kasamatsu A; Koike H; Kouzu Y; Shinozuka K; Nakatani K; Negoro K; Fujita S; Tanzawa H
Int J Cancer; 2010 Jan; 126(2):437-49. PubMed ID: 19569180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
